Unknown

Dataset Information

Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells.


ABSTRACT:

Background

Osteosarcoma (OS) is a malignant tumor of the bone mostly observed in children and adolescents. The current treatment approach includes neoadjuvant and adjuvant chemotherapy; however, drug resistance often hinders therapy in OS patients. Also, the post-relapse survival of OS patients is as low as 20%. We therefore planned to understand the molecular cause for its poor prognosis and design an appropriate therapeutic strategy to combat the disease.

Methods

We analyzed OS patient dataset from Gene Expression Omnibus (GEO) and identified the differentially expressed genes and the top deregulated pathways in OS. Subsequently, drugs targeting the major de-regulated pathways were selected and the following assays were conducted- MTT assay to assess cytotoxicity of drugs

SUBMITTER: Saini H 

PROVIDER: S-EPMC7807844 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature